Research Database

20 studies found

Positive

70.0%

Negative

5.0%

Inconclusive

25.0%

Page 1 of 1

InconclusiveReview/Other

P453 A study on patient and healthcare provider experiences with outpatient sexual and reproductive healthcare for adults with cystic fibrosis: insights from a single-center study

2025

Fibrosis - Lung

PositiveReview/Other

Targeting cannabinoid receptor 1 for antagonism in pro-fibrotic alveolar macrophages mitigates pulmonary fibrosis

2025

Diabetes

InconclusiveReview/Other

Cannabinoid receptor 2 agonist, lenabasum, for the treatment of pulmonary exacerbations in cystic fibrosis

2025

Fibrosis - Lung

InconclusiveReview/Other

Patent review of cannabinoid receptor type 2 (CB2R) modulators (2016-present)

2024

Cancer

PositiveReview/Other

The Effect of Ocimum basilicum L. and Its Main Ingredients on Respiratory Disorders: An Experimental, Preclinical, and Clinical Review

2022

Asthma

PositiveReview/Other

Endocannabinoid signalling/cannabinoid receptor 2 is involved in icariin-mediated protective effects against bleomycin-induced pulmonary fibrosis

2022

COPD

PositiveReview/Other

Fatty Acid Amide Hydrolase (FAAH) Inhibition Plays a Key Role in Counteracting Acute Lung Injury

2022

Acute Respiratory Distress Syndrome

PositiveReview/Other

D-Limonene Is a Potential Monoterpene to Inhibit PI3K/Akt/IKK-α/NF-κB p65 Signaling Pathway in Coronavirus Disease 2019 Pulmonary Fibrosis

2021

COVID-19

PositiveReview/Other

The effects of systemic and local fatty acid amide hydrolase and monoacylglycerol lipase inhibitor treatments on the metabolomic profile of lungs

2021

Inflammation

InconclusiveReview/Other

Acute lung injury-from cannabis to COVID

2021

Acute Respiratory Distress Syndrome

PositiveReview/Other

CB1R and iNOS are distinct players promoting pulmonary fibrosis in Hermansky–Pudlak syndrome

2021

Fibrosis - Lung

PositiveReview/Other

Cannabinoids—A New Perspective in Adjuvant Therapy for Pulmonary Hypertension

2021

Cardiovascular Diseases (CVD)

PositiveReview/Other

The potential of cannabinoids and inhibitors of endocannabinoid degradation in respiratory diseases

2021

COVID-19

InconclusiveAnimal Study - Veterinary Clinical Trial

A clinician survey of use assessment, documentation, and education about cannabis in persons with cystic fibrosis

2021

Fibrosis - Lung

NegativeMeta-analysis -

Cannabis Inhalation and Voice Disorders: A Systematic Review

2019

Cannabis Adverse Effects

PositiveAnimal Study -

Activation of cannabinoid receptor type 2 by JWH133 alleviates bleomycin-induced pulmonary fibrosis in mice

2017

Fibrosis - Lung

PositiveReview/Other

Ultramicronized palmitoylethanolamide (PEA-um(®)) in the treatment of idiopathic pulmonary fibrosis

2016

Fibrosis - Lung

PositiveReview/Other

Cannabinoids, Inflammation, and Fibrosis

2016

Cardiovascular Diseases (CVD)

PositiveReview/Other

Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis.

2012

Fibrosis - Lung

PositiveReview/Other

Targets of curcumin

2011

Allergic Contact Dermatitis

Command Palette

Research Database

P453 A study on patient and healthcare provider experiences with outpatient sexual and reproductive healthcare for adults with cystic fibrosis: insights from a single-center study

Targeting cannabinoid receptor 1 for antagonism in pro-fibrotic alveolar macrophages mitigates pulmonary fibrosis

Cannabinoid receptor 2 agonist, lenabasum, for the treatment of pulmonary exacerbations in cystic fibrosis

Patent review of cannabinoid receptor type 2 (CB2R) modulators (2016-present)

The Effect of Ocimum basilicum L. and Its Main Ingredients on Respiratory Disorders: An Experimental, Preclinical, and Clinical Review

Endocannabinoid signalling/cannabinoid receptor 2 is involved in icariin-mediated protective effects against bleomycin-induced pulmonary fibrosis

Fatty Acid Amide Hydrolase (FAAH) Inhibition Plays a Key Role in Counteracting Acute Lung Injury

D-Limonene Is a Potential Monoterpene to Inhibit PI3K/Akt/IKK-α/NF-κB p65 Signaling Pathway in Coronavirus Disease 2019 Pulmonary Fibrosis

The effects of systemic and local fatty acid amide hydrolase and monoacylglycerol lipase inhibitor treatments on the metabolomic profile of lungs

Acute lung injury-from cannabis to COVID

CB1R and iNOS are distinct players promoting pulmonary fibrosis in Hermansky–Pudlak syndrome

Cannabinoids—A New Perspective in Adjuvant Therapy for Pulmonary Hypertension

The potential of cannabinoids and inhibitors of endocannabinoid degradation in respiratory diseases

A clinician survey of use assessment, documentation, and education about cannabis in persons with cystic fibrosis

Cannabis Inhalation and Voice Disorders: A Systematic Review

Activation of cannabinoid receptor type 2 by JWH133 alleviates bleomycin-induced pulmonary fibrosis in mice

Ultramicronized palmitoylethanolamide (PEA-um(®)) in the treatment of idiopathic pulmonary fibrosis

Cannabinoids, Inflammation, and Fibrosis

Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis.

Targets of curcumin